pyrazinamide has been researched along with Allergic Encephalomyelitis in 1 studies
pyrazinecarboxamide : A monocarboxylic acid amide resulting from the formal condensation of the carboxy group of pyrazinoic acid (pyrazine-2-carboxylic acid) with ammonia. A prodrug for pyrazinoic acid, pyrazinecarboxamide is used as part of multidrug regimens for the treatment of tuberculosis.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jenh, CH | 1 |
| Cox, MA | 1 |
| Cui, L | 1 |
| Reich, EP | 1 |
| Sullivan, L | 1 |
| Chen, SC | 1 |
| Kinsley, D | 1 |
| Qian, S | 1 |
| Kim, SH | 1 |
| Rosenblum, S | 1 |
| Kozlowski, J | 1 |
| Fine, JS | 1 |
| Zavodny, PJ | 1 |
| Lundell, D | 1 |
1 other study available for pyrazinamide and Allergic Encephalomyelitis
| Article | Year |
|---|---|
A selective and potent CXCR3 antagonist SCH 546738 attenuates the development of autoimmune diseases and delays graft rejection.
Topics: Animals; Arthritis, Experimental; Arthritis, Rheumatoid; Autoimmune Diseases; Chemotaxis, Leukocyte; | 2012 |